<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1-5954-24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZINACEF 750 mg
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFUROXIME SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        750
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Parenteral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        powder for solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        37.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ACS Dobfar S.P.A" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ACS Dobfar S.P.A
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 5182]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Sandoz Limited Trading
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Sandoz Pharmaceuticals d.d
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ZINACEF is an antibiotic and works by killing bacteria that cause infections. It belongs to a group of medicines called <em>cephalosporins</em>.</p><p>ZINACEF is used in adults and children to treat infections of the:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lungs or chest</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ears, nose and throat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary tract</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bones and joints</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; female reproductive organs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; brain (<em>meningitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abdomen (<em>peritonitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood (<em>septicaemia</em>).</p><p>ZINACEF is also used to:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; treat a sexually transmitted infection called<em> gonorrhoea</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prevent infections during surgery.</p><p>&nbsp;</p><p>Your doctor should test the type of bacteria causing your infection and monitor whether the bacteria are sensitive to ZINACEF during your treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Don&rsquo;t use ZINACEF </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; if you&rsquo;re allergic <em>(hypersensitive)</em> to antibiotics, or any of the other ingredients of ZINACEF</p><p>&ccedil; <strong>If you think this applies to you, tell with your doctor before you are given ZINACEF. </strong></p><p><strong>Take special care with ZINACEF</strong></p><p><strong>Look out for important symptoms</strong></p><p>ZINACEF can cause serious side effects such as hearing loss (when used to treat meningitis), allergic reactions, fungal infections and severe diarrhoea (<em>pseudomembranous colitis</em>). You must look out for certain symptoms while you are taking ZINACEF, to reduce the risk of any problems. See &lsquo;<em>Look out for important symptoms&rsquo;</em> in Section 4.</p><p><strong>While you are using ZINACEF</strong></p><p><strong>Before you are given ZINACEF your doctor needs to know: </strong></p><p>&nbsp; if you have kidney disease</p><p>&nbsp; if you&#39;re over 75 year of age</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Check with your doctor if you think any of these may apply to you.</strong></p><p><strong>If you need a blood test</strong></p><p>ZINACEF can affect the results of some tests for blood sugar levels, or a blood test called the Coombs test. If you need a blood test:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Tell the person taking the blood sample that you have been given ZINACEF.</strong></p><p><strong>Other medicines and ZINACEF </strong></p><p>Tell your doctor if you&rsquo;re taking any other medicines, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription.</p><p>Some medicines may affect how ZINACEF works or make it more likely that you&rsquo;ll have side effects. These include:</p><ul><li>water tablets (diuretics), such as frusemide</li><li>aminoglycoside-type antibiotics.</li></ul><p>&ccedil; <strong>Check with your doctor if you think any of these may apply to you. You may need extra check-ups to monitor your kidney function while you are taking ZINACEF.</strong></p><p><strong>Contraceptive pill</strong></p><p>ZINACEF may reduce how well the contraceptive pill works. If you are taking the contraceptive pill while you are being treated with ZINACEF you also need to use a barrier method of contraception (such as condoms). Ask your doctor for advice.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>There is limited information about the safety of ZINACEF in pregnant women. If you are pregnant your doctor will consider the benefit to you against the risk to your baby of treating you with ZINACEF.</p><p>The ingredients in ZINACEF can pass into breast milk. If you are breast-feeding, check with your doctor before you are given ZINACEF.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ZINACEF will usually be given by a doctor or nurse as an injection either directly into a vein (<em>intravenously</em>) or into a muscle (<em>intramuscularly</em>). In some cases, it may be given as a drip (<em>intravenous infusion</em>).</p><p><strong>The usual dose</strong></p><p>Your doctor will decide on the correct dose of ZINACEF that is right for you. It will depend on:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; the severity and type of infection you have</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; whether you are taking any other antibiotics</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; your weight and age</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; how well your kidneys are working.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ZINACEF can cause side effects, but not everybody gets them.</p><p><strong>Look out for important symptoms</strong></p><p><strong>Severe allergic reactions</strong></p><p>These are very rare in people taking ZINACEF. Signs include:</p><p>&nbsp; raised and itchy rash (<em>hives</em>)</p><p>&nbsp; swelling, sometimes of the face or mouth (<em>angioedema</em>), causing difficulty in breathing</p><p>&nbsp; collapse.</p><p><strong>&nbsp;</strong></p><p>&ccedil;&nbsp;&nbsp; <strong>Contact a doctor immediately if you get any of these symptoms.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Serious skin reactions</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (<em>erythema multiforme)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; a widespread rash with blisters and skin peeling on much of the body surface<em> (toxic epidermal necrolysis)</em>, particularly around the mouth, nose, eyes or genitals (<em>Stevens-Johnson syndrome</em>).</p><p><strong>&nbsp;</strong></p><p>&ccedil;&nbsp;&nbsp; <strong>Contact a doctor immediately</strong><strong> if you get these symptoms.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Fungal infections</strong></p><p>On rare occasions, medicines like ZINACEF can cause an overgrowth of yeast (<em>Candida</em>) in the body which can lead to fungal infections (such as thrush). This side effect is more likely to occur if you take ZINACEF for a long time.</p><p><strong>&nbsp;</strong></p><p>&ccedil;&nbsp;&nbsp; <strong>Tell your doctor as soon as possible</strong><strong> if you think you have a fungal infection. Your doctor may need to stop your treatment.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Hearing loss in children with meningitis</strong></p><p>Children who have been treated with medicines like ZINACEF for meningitis have experienced mild-to-moderate hearing loss. This has happened in a very small number of patients, although the exact frequency is unknown.</p><p><strong>Severe diarrhoea (Pseudomembranous colitis)</strong></p><p>On very rare occasions, medicines like ZINACEF can cause inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain, fever.</p><p>&ccedil;&nbsp;&nbsp; <strong>Tell your doctor as soon as possible </strong>if you get any of these symptoms.</p><p><strong>Common side effects</strong></p><p>These may affect up to 1 in 10 people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; injection site pain, swelling and redness along a vein</p><p>Common side effects that may show up in blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increases in substances (<em>enzymes</em>) produced by the liver</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your white blood cell count (<em>neutropenia </em>or<em> eosinophilia</em>)</p><p><strong>Uncommon side effects</strong></p><p>These may affect up to 1 in 100 people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, itchy, bumpy rash (<em>hives</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea, nausea, vomiting</p><p>Uncommon side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low levels of white blood cells (<em>leukopenia</em>) and red blood cells (<em>anaemia</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in bilirubin (a substance produced by the liver).</p><p><strong>Rare side effects</strong></p><p>These may affect up to 1 in 1,000 people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fungal infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high temperature (<em>fever</em>)</p><p>Rare side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in number of blood platelets (cells that help blood to clot - <em>thrombocytopenia</em>)</p><p><strong>Very rare side effects</strong></p><p>These may affect up to 1 in 10,000 people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain, fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation in the kidney and blood vessels</p><p>Very rare side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in levels of urea nitrogen and serum creatinine in the blood.</p><p><strong>&nbsp;</strong></p><p><strong>If you get side effects</strong></p><p>&ccedil; <strong>Tell your doctor or pharmacist if any of the side effects listed becomes severe or troublesome, or if you notice any side effects not listed in this leaflet.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Keep out the reach and sight of children.</strong></p><p>Do not use ZINACEF after the expiry date which is stated on the vial label or carton after &lsquo;Exp&rsquo;.</p><p>Keep the vial in the outer carton to protect from light.</p><p>&nbsp;Do not store above 25&deg;C.</p><p><u>Unopened product previously stored below 25<sup>o</sup>C</u></p><p><strong>Shelf life after reconstitution and dilution under controlled and validated aseptic conditions:</strong></p><p>suspension and solution for Injection -5 hours below 25<sup>o</sup>C or 72 hours at 2 to 8<sup>o</sup>C</p><p><strong>Shelf life if reconstitution and dilution has not taken place in controlled and validated aseptic conditions:</strong></p><p>The product should be used immediately or within 24 hours if stored at 2 to 8<sup>o</sup>C.</p><p><u>Unopened product previously stored below 30<sup>o</sup>C</u></p><p><strong>Shelf life after reconstitution and dilution under controlled and validated aseptic conditions:</strong></p><p>Suspension and solution for Injection -5 hours below 25<sup>o</sup>C or 72 hours at 2 to 8<sup>o</sup>C</p><p><strong>Shelf life if reconstitution and dilution has not taken place in controlled and validated aseptic conditions:</strong></p><p>The product should be used immediately or within 24 hours if stored at 2&deg; to 8&deg;C.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is cefuroxime sodium.</p><p><strong>Active ingredients:</strong></p><p>&nbsp;</p><p>ZINACEF 750 mg vial: Each powder for injection contains 750 mg cefuroxime [as cefuroxime sodium]</p><p>ZINACEF 1.5 g vial: Each powder for injection contains 1.5 g cefuroxime [as cefuroxime sodium]</p><p>&nbsp;</p><p><strong>Excipients</strong></p><p>Each 750 mg vial contains 42 mg sodium (1.8 mEq).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ZINACEF 750 mg injection: White to cream powder for injection containing 750 mg of cefuroxime.

ZINACEF 1.5 g injection: White to cream powder for injection containing 1.5 g of cefuroxime.

Not All packs are marketed in every country.

ZINACEF is a trademark owned by or licensed to the GSK group of companies.
© 2020 GSK group of companies. All rights reserved.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:</strong></p><p>ACS Dobfar S.p.A.* Verona, Italy.</p><p><strong>Packed by:</strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p><strong>Marketing Authorization Holder: </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia.</p><p>*member of the GlaxoSmithKline group of companies</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                GDS Version Number: GDS33
Date of issue: 26 March 2020

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">زيناسيف هو مضاد حيوي يعمل على قتل البكتيريا المسببة للعدوى. وهو ينتمي إلى مجموعة من الأدوية تسمى السيفالوسبورين</p><p dir="RTL">يستخدم زيناسيف في البالغين والأطفال لعلاج عدوى:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرئتين أو الصدر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأنف والأذن والحنجرة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المسالك البولية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الجلد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;العظام والمفاصل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الأعضاء التناسلية في الإناث</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المخ (الالتهاب السحائي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البطن (التهاب الصفاق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدم (إنتان الدم)</p><p dir="RTL">كما يستخدم زيناسيف أيضًا في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج العدوى المنقولة جنسيًا والمسماة بالسيلان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; منع حدوث العدوى أثناء الجراحة</p><p>&nbsp;</p><p dir="RTL">يجب على طبيبك اختبار نوع البكتيريا المسببة للعدوى ومراقبة حساسية البكتيريا لدواء زيناسيف أثناء العلاج.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول زيناسيف في الحالات التالية</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من الحساسية (<em>فرط الحساسية</em>) من المضادات الحيوية أو أي من مكونات زيناسيف الأخرى</p><p dir="RTL">&ccedil;&nbsp; <strong>إذا كنت تعتقد أن هذا ينطبق عليك، أخبر طبيبك قبل تناول زيناسيف</strong></p><p dir="RTL"><strong>&nbsp;احذر جيدًا عند تناول زيناسيف</strong><strong> </strong></p><p dir="RTL"><strong>واحذر الأعراض المهمة</strong></p><p dir="RTL">قد يسبب زيناسيف آثارًا جانبية خطيرة مثل فقدان السمع (عند استخدامه لعلاج التهاب السحايا)، والحساسية، والالتهابات الفطرية والإسهال الشديد <em>(التهاب القولون الغشائي الكاذب)</em>. يجب اتخاذ الحذر من بعض الأعراض المحددة عند تناول زيناسيف، وذلك لتقليل المخاطرة بحدوث أي مشاكل أنظر فقرة &ldquo;<em>احذر الأعراض المهمة&quot;</em> في القسم رقم 4</p><p dir="RTL"><strong>أثناء تناول زيناسيف</strong></p><p dir="RTL"><strong>يجب أن يعلم طبيبك ما يلي قبل أن يصف لك زيناسيف:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>&nbsp;إذا كنت تعاني من أمراض بالكلى،</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كان عمرك يتخطى 75 عامًا.</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>استشر طبيبك إنْ كنت تظن أن أي مما سبق ينطبق عليك</strong></p><p dir="RTL"><strong>إذا كنت تحتاج لعمل اختبار الدم</strong></p><p dir="RTL">قد يؤثر زيناسيف على نتائج بعض اختبارات الدم، مثل اختبار مستوى السكر في الدم أو أختبار الدم المسمى &quot;اخْتِبارُ كومبس&quot; إذا كنت تحتاج لعمل تحليل الدم:</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أخبر الشخص القائم بسحب العينة أنك تتناول زيناسيف</strong></p><p dir="RTL"><strong>زيناسيف والأدوية الأخرى</strong></p><p dir="RTL">&nbsp;أخبر طبيبك إذا كنت تتناول أي أدوية أخرى، أو إذا كنت قد تناولت أي منها مؤخرًا، أو إذا بدأت في تناول أدوية جديدة. ويشمل ذلك الأدوية التي اشتريتها دون وصفة طبية.</p><p dir="RTL">قد تؤثر بعض الأدوية على كيفية عمل زيناسيف، أو تزيد من إحتمال تعرضك لأعراض جانبية. وتشمل هذه الأدوية ما يلي:</p><ul><li dir="RTL">حبوب الماء (مدرات البول) مثل فروسيميد</li><li dir="RTL">المضادات الحيوية من نوع أمينوجليكوزيد</li></ul><p dir="RTL"><strong>&ccedil;&nbsp; </strong><strong>&nbsp;استشر طبيبك إنْ كنت تظن أن أي مما سبق ينطبق عليك قد تحتاج إلى إجراء بعض الفحوصات الإضافية لمراقبة وظائف الكلى أثناء تناولك زيناسيف.</strong></p><p dir="RTL"><strong>حبوب منع الحمل</strong></p><p dir="RTL">قد يقلل زيناسيف من جودة تأثير حبوب منع الحمل. إذا كنتِ تتناولين حبوب منع الحمل أثناء العلاج باستخدام زيناسيف، فيجب أيضًا استخدام طريقة أخرى مانعة للحمل (مثل الواقي الذكري). استشر طبيبك</p><p dir="RTL"><strong>الحمل والإرضاع</strong></p><p dir="RTL">تعد المعلومات المتوافرة حول مدى سلامة استخدام الحوامل لدواء زيناسيف محدودة. إذا كنتِ حاملاً، سيقارن طبيبك الفائدة التي تعود عليكِ من العلاج بدواء زيناسيف أمام المخاطر التي قد تواجه طفلك</p><p dir="RTL">قد تنتقل مكونات دواء زيناسيف إلى طفلك عن طريق الرضاعة. إذا كنت ترضعين طفلك رضاعة طبيعية فاستشيري طبيبك قبل أن يصف لكِ زيناسيف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;عادة ما يتم إعطاء زيناسيف بمعرفة الطبيب أو الممرضة كحقن إما في الوريد مباشرة أو في العضل. وفي بعض الحالات يمكن إعطاؤه بالتنقيط (التسريب في الوريد)</p><p dir="RTL"><strong>الجرعة المعتادة</strong></p><p dir="RTL">سيقرر طبيبك الجرعة الصحيحة والمناسبة لك من زيناسيف، وهو ما يعتمد على ما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;نوع وشدة العدوى التي تعاني منها،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ما إذا كنت تتناول أي مضادات حيوية أخرىن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; وزنك وعمرك،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; كفاءة الكلى لديك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب زيناسيف آثارًا جانبية، ولكن لا يُشترَط أن يصاب بها الجميع.</p><p dir="RTL"><strong>&nbsp;احذر من الأعراض المهمة</strong></p><p dir="RTL"><strong>أعراض الحساسية الشديدة</strong></p><p dir="RTL">وهي شديدة الندرة في الأشخاص الذين يتناولون زيناسيف وتشمل أعراضها ما يلي:</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>طفح جلدي ناتئ ومثير للحكة <em>(شَرَى)</em></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>قد يحدث في بعض الأحيان تورم في الوجه أو الفم <em>(وذمة وعائية)</em> مما يسبب صعوبة في التنفس</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الانهيار</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>اتصل بطبيبك على الفور في حال عانيت من أيٍّ من هذه الأعراض</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأعراض الجلدية الخطيرة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي قد يتقرح ويتخذ شكل البقع الصغيرة (بقع داكنة مركزية محاطة بمنطقة شاحبة، مع حلقة داكنة حول الحافة) (حُمامَى عَديدَةُ الأَشْكال)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي واسع الانتشار مع تقرحات وتقشير للجلد على جزء كبير من سطح الجسم <em>(انحلال البشرة السمي)</em> وخاصة حول الفم أو الأنف أو العينين أو الأعضاء التناسلية <em>(متلازمة ستيفنز جونسون).</em></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>اتصل بطبيبك على الفور في حال عانيت من أيٍّ من هذه الأعراض</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>العدوى الفطرية</strong></p><p dir="RTL">في بعض الحالات النادرة يمكن أن تسبب الأدوية مثل زيناسيف فرط نمو الخميرة (<em>المبيضات</em>) في الجسم مما قد يؤدي إلى عدوى فطرية (مثل السُلاَق الفموي). وتزيد احتمالات الإصابة بهذا العَرَض الجانبي في حال استمرار العلاج بدواء زيناسيف لفترة طويلة</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أخبر طبيبك في أسرع وقت ممكن إذا كنت تعتقد في إصابتك بعدوى فطرية، فقد يحتاج طبيبك حينها إلى وقف العلاج</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>فقدان السمع لدى الأطفال المصابين بالتهاب السحايا</strong></p><p dir="RTL">عانى بعض الأطفال الذين عولجوا من التهاب السحايا باستخدام أدوية مثل زيناسيف من ضعف خفيف إلى متوسط بالسمع. وقد حدث هذا في عدد قليل جدًا من المرضى، على الرغم من عدم توفر عدد مرات الإصابة بهذا العَرَض بدقة.</p><p dir="RTL"><strong>الإسهال الشديد (التهاب القولون الغشائي الكاذب)</strong></p><p dir="RTL">في حالات نادرة جدًا يمكن أن تسبب أدوية مثل &quot;زيناسيف&quot; التهاب القولون (الأمعاء الغليظة)، مما قد يسبب الإسهال، والذي يكون مصحوبًا عادة بالدم والمخاط، وآلام المعدة والحمى.</p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أخبر طبيبك على الفور</strong><strong> في حال عانيت من أيٍّ من هذه الأعراض</strong></p><p dir="RTL"><strong>الآثار الجانبية المعتادة</strong></p><p dir="RTL">قد تصيب الى حد شخصَا واحدًا من كل 10 أشخاص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ألم مكان الحقن، وتورم واحمرار على طول الوريد</p><p dir="RTL">الأعراض الجانبية المعتادة التي قد تظهر في اختبارات الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في المواد (الإنزيمات) التي يفرزها الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغير في عدد خلايا الدم البيضاء <em>(قلة العدلات أو فرط اليُوزينِيَّات)</em></p><p dir="RTL"><strong>الآثار الجانبية غير المعتادة</strong></p><p dir="RTL">قد تصيب الى حد شخصَا واحدًا من كل 100 شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;طفح جلدي وحكة أو طفح ناتئ <em>(شَرَى)</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال، الدوار، القيء</p><p dir="RTL">الآثار الجانبية غير المعتادة التي قد تظهر في اختبارات الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات منخفضة من خلايا الدم البيضاء (نقص الكريات البيض) وخلايا الدم الحمراء (فقر الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة البيليروبين (مادة يفرزها الكبد).</p><p dir="RTL"><strong>الآثار الجانبية النادرة</strong></p><p dir="RTL">قد تصيب الى حد شخصَا واحدًا من كل 1,000 شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;العدوى الفطرية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع درجة الحرارة (الحمى)</p><p dir="RTL">الآثار الجانبية النادرة التي قد تظهر في اختبارات الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية (الخلايا التي تساعد الدم على التجلط -<em>قلة الصفيحات</em>)</p><p dir="RTL"><strong>الآثار الجانبية شديدة الندرة</strong></p><p dir="RTL">قد تصيب الى حد شخصَا واحدًا من كل 10,000 شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;أعراض الحساسية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب القولون (الأمعاء الغليظة)، مما قد يسبب الإسهال، والذي يكون مصحوبًا عادة بالدم والمخاط، وآلام المعدة والحمى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكلى والأوعية الدموية</p><p dir="RTL">الآثار الجانبية شديدة الندرة التي قد تظهر في اختبارات الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في مستويات نيتروجين اليوريا والكرياتينين في الدم.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا عانيت من أي آثار جانبية</strong></p><p><strong>يرجى إبلاغ طبيبك أو الصيدلي إذا اشتدت عليك أي من الآثار الجانبية أو سببت لك مشاكل صحية، أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يُرجى إبقاء الدواء بعيدًا عن متناول الأطفال وعن مدى بصرهم</strong></p><p dir="RTL">لا تستخدم زيناسيف بعد تاريخ انتهاء الصلاحية المدون على ملصق القارورة أو الكرتونة بعد كلمة &quot;انتهاء- Exp.&quot;</p><p dir="RTL">يُرجى الحفاظ على القارورة داخل الكرتونة الخارجية لحمايتها من التعرض للضوء</p><p dir="RTL">&nbsp;لا تحفظ الدواء في درجة حرارة تتجاوز 25&deg; مئوية</p><p dir="RTL"><u>المنتَج غير المفتوح المحفوظ مسبقًا في درجة حرارة تحت 25 درجة مئوية</u></p><p dir="RTL"><strong>مدة الصلاحية بعد إعادة التشكيل والتخفيف في بيئة مراقبة من جهة شروط التعقيم الدقيقة والصحيحة:</strong></p><p dir="RTL">معلق ومحلول للحقن -5 ساعات في درجة حرارة تحت 25 درجة مئوية أو 72 ساعة في درجة حرارة تتراوح ما بين2-8 درجات مئوية</p><p dir="RTL"><strong>مدة الصلاحية في حال لم تحدث إعادة التشكيل والتخفيف في بيئة مراقبة من جهة شروط التعقيم الدقيقة والصحيحة:</strong></p><p dir="RTL">يجب استخدام المنتج فورًا أو خلال 24 ساعة إذا تم حفظه في درجة حرارة تتراوح ما بين 2-8 درجات مئوية</p><p dir="RTL"><u>المنتَج المغلق والمحفوظ مسبقًا في درجة حرارة تحت 30 درجة مئوية</u></p><p dir="RTL"><strong>مدة الصلاحية بعد إعادة التشكيل والتخفيف في بيئة مراقبة من جهة شروط التعقيم الدقيقة والصحيحة:</strong></p><p dir="RTL">معلق ومحلول للحقن -5 ساعات في درجة حرارة تحت 25 درجة مئوية أو 72 ساعة في درجة حرارة تتراوح ما بين 2-8 درجات مئوية</p><p dir="RTL"><strong>مدة الصلاحية في حال لم تحدث إعادة التشكيل والتخفيف في بيئة مراقبة من جهة شروط التعقيم الدقيقة والصحيحة:</strong></p><p dir="RTL">يجب استخدام المنتج فورًا أو خلال 24 ساعة إذا تم حفظه في درجة حرارة تتراوح ما بين 2-8 درجات مئوية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ) ما هي محتويات زيناسيف</strong></p><p dir="RTL">المادة الفعالة هي سيفوروكسيم الصوديوم</p><p dir="RTL"><strong>&nbsp;المكونات النشطة:</strong></p><p>&nbsp;</p><p dir="RTL">زيناسيف 750 ملجم للحقن الوريدي كل مسحوق للحقن يحتوي على 750 ملجم من سيفوروكسيم [في شكل سيفوروكسيم الصوديوم]</p><p dir="RTL">زيناسيف 1.5 جم للحقن الوريدي كل مسحوق للحقن يحتوي على 1.5 جم من سيفوروكسيم [في شكل سيفوروكسيم الصوديوم]</p><p>&nbsp;</p><p dir="RTL"><strong>المكونات غير الأساسية</strong></p><p dir="RTL">لا يوجد</p><p dir="RTL">تحتوي كل قارورة 750 ملجم للحقن الوريدي على 42 ملجم من الصوديوم (1.8 ملي مكافئ)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ب) كيف تبدو عبوة زيناسيف وما هي محتوياتها</strong></p><p dir="RTL"><em>كما هو مسجل محليًا</em></p><p dir="RTL">&nbsp;زيناسيف 750 ملجم للحقن: مسحوق أبيض إلى كريمي اللون للحقن يحتوي على 750 ملجم سيفوروكسيم</p><p dir="RTL">زيناسيف 1.5 جم للحقن: مسحوق أبيض إلى كريمي اللون للحقن يحتوي على 1.5 جم سيفوروكسيم</p><p><em>&nbsp;</em></p><p dir="RTL"><strong><em>لا يتم تسويق جميع أنواع العبوات في جميع البلاد</em></strong></p><p>&nbsp;</p><p dir="RTL">زيناسيف هي علامة تجارية مملوكة أو مرخصة لصالح مجموعة شركات جلاكسو سميث كلاين</p><p dir="RTL">&copy; 2020، مجموعة شركات جلاكسو سميث كلاين. جميع الحقوق محفوظة</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الجهة المصنعة:</strong></p><p dir="RTL">إيه سي إس دوبفار إس بي إيه*، فيرونا، إيطاليا</p><p dir="RTL"><strong>جهة التعبئة:</strong></p><p dir="RTL">جلاكسو السعودية المحدودة*، جدة، المملكة العربية السعودية</p><p dir="RTL"><strong>الجهة المفوضة بالتسويق:</strong></p><p dir="RTL">جلاكسو السعودية المحدودة*، جدة، المملكة العربية السعودية</p><p dir="RTL">العنوان: صندوق بريد 22617، جدة 21416 -المملكة العربية السعودية؛</p><p dir="RTL">*عضو مجموعة شركات جلاكسو سميث كلاين</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
رقم الإصدار: GDS33
تاريخ الإصدار: 26 مارس 2020

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZINACEF
Cefuroxime sodium 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZINACEF Injection contains 750 mg and 1.5 g of cefuroxime (as cefuroxime sodium). 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZINACEF Injection: Powder for suspension or solution for injection and Powder for solution for infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>ZINACEF </em>is a bactericidal cephalosporin antibiotic which is resistant to most beta-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms.</p><p><br />&nbsp;</p><p>It is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. Susceptibility to <em>ZINACEF </em>will vary with geography and time and local susceptibility data should be consulted where available (<em>see Pharmacological properties, Pharmacodynamics</em>).</p><p>&nbsp;</p><p>Indications include:</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; respiratory tract infections for example, acute exacerbation of chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; soft-tissue infections for example, cellulitis, erysipelas and wound infections</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bone and joint infections for example, osteomyelitis and septic arthritis</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; obstetric and gynaecological infections, pelvic inflammatory diseases</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gonorrhoea particularly when penicillin is unsuitable</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other infections including septicaemia, meningitis and peritonitis</p><p>&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection.</p><p>&nbsp;</p><p>Usually <em>ZINACEF </em>will be effective alone, but when appropriate it may be used in combination with an aminoglycoside antibiotic, or in conjunction with metronidazole (orally or by suppository or injection), especially for prophylaxis in colonic or gynaecological surgery.</p><p>&nbsp;</p><p>Where appropriate <em>ZINACEF </em>is effective when used prior to oral therapy with <em>ZINNAT </em>(cefuroxime axetil) in the treatment of pneumonia and acute exacerbations of chronic bronchitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmaceutical forms:</p><p>ZINACEF Injection: Powder for suspension or solution for injection and Powder for solution for infusion</p><p>ZINACEF Injection is for intravenous (i.v.) and/or intramuscular (i.m.) administration only.</p><p><em>ZINACEF </em>is also available as the axetil ester (<em>ZINNAT</em>for oral administration. This permits the use of sequential therapy with the same antibiotic, when a change from parenteral to oral therapy is clinically indicated.</p><p>No more than 750 mg should be injected at one intramuscular site.</p><p>&nbsp;</p><p>GENERAL DOSING RECOMMENDATIONS&nbsp;</p><p>&nbsp;</p><p>Adults</p><p>Many infections respond to 750 mg three times daily by i.m. or i.v. injection. For more severe infections the dose should be increased to 1.5 g three times daily given i.v. The frequency of administration may be increased to 6-hourly if necessary, giving total daily doses of 3 to 6 g. Where clinically indicated, some infections respond to 750 mg or 1.5 g twice daily (i.v. or i.m.) followed by oral therapy with <em>ZINNAT</em>.</p><p>&nbsp;</p><p>Infants and Children</p><p>30 to 100 mg/kg/day given as 3 or 4 divided doses. A dose of 60 mg/kg/day is appropriate for most infections.</p><p><strong>&nbsp;</strong></p><p>Neonates</p><p>30 to 100 mg/kg/day given as 2 or 3 divided doses (<em>see Pharmacokinetics</em>).</p><p>&nbsp;</p><p>GONORRHOEA</p><p>Adults</p><p>1.5 g as a single dose (as 2 x 750 mg injections given i.m.with different sites e.g. each buttock).</p><p>&nbsp;</p><p>MENINGITIS</p><p><em>ZINACEF </em>is suitable for sole therapy of bacterial meningitis due to sensitive strains.</p><p>&nbsp;</p><p><strong>Adults: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </strong>3 g given i.v. every 8 hours.</p><p><strong>Infants and Children:&nbsp; </strong>- 150 to 250 mg/kg/day given i.v. in 3 or 4 divided doses</p><p><strong>Neonates: &nbsp;&nbsp;&nbsp; - </strong>the dosage should be 100 mg/kg/day given i.v.</p><p>&nbsp;</p><p>PROPHYLAXIS</p><p>The usual dose is 1.5 g given i.v. with induction of anaesthesia for abdominal, pelvic and orthopaedic operations. This may be supplemented with two 750 mg i.m. doses 8 and</p><p>16 hours later.</p><p>&nbsp;</p><p>In cardiac, pulmonary, oesophageal and vascular operations, the usual dose is 1.5 g given</p><p>i.v. with induction of anaesthesia, continuing with 750 mg given i.m. three times daily for a further 24 to 48 hours.</p><p>&nbsp;</p><p>In total joint replacement, 1.5 g <em>ZINACEF </em>powder may be mixed dry with each pack of methyl methacrylate cement polymer before adding the liquid monomer.</p><p>&nbsp;</p><p>SEQUENTIAL THERAPY</p><p>Adults</p><p>Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.</p><p>&nbsp;</p><p>Pneumonia</p><p>1.5 g <em>ZINACEF </em>three times daily or twice daily (given i.v. or i.m.) for 48 to 72 hours, followed by 500 mg twice daily <em>ZINNAT </em>(cefuroxime axetil) oral therapy for 7 to10 days.</p><p>Acute exacerbations of chronic bronchitis</p><p>&nbsp;</p><p>750 mg <em>ZINACEF </em>three times daily or twice daily (given i.v. or i.m.) for 48 to 72 hours, followed by 500 mg twice daily <em>ZINNAT </em>(cefuroxime axetil) oral therapy for 5 to10 days.</p><p>&nbsp;</p><p>RENAL IMPAIRMENT</p><p>&nbsp;</p><p>Cefuroxime is excreted by the kidneys. Therefore, as with all such antibiotics, in patients with markedly impaired renal function it is recommended that the dosage of <em>ZINACEF </em>should be reduced to compensate for its slower excretion.</p><p>&nbsp;</p><p>It is not necessary to reduce the standard dose (750 mg to 1.5 g three times daily) until the creatinine clearance falls to 20 ml/min or below.</p><p>&nbsp;</p><p>In adults with marked impairment (creatinine clearance 10 to 20 ml/min) 750 mg twice daily is recommended and with severe impairment (creatinine clearance &lt;10 ml/min)</p><p>750 mg once daily is adequate.</p><p>&nbsp;</p><p>For patients on haemodialysis a further 750 mg dose should be given i.v. or i.m. at the end of each dialysis. In addition to parenteral use, <em>ZINACEF </em>can be incorporated into the peritoneal dialysis fluid (usually 250 mg for every 2 litres of dialysis fluid).</p><p>&nbsp;</p><p>For patients in renal failure on continuous arteriovenous haemodialysis or high-flux haemofiltration in intensive therapy units a suitable dosage is 750 mg twice daily. For low-flux haemofiltration follow the dosage recommended under impaired renal function.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to cephalosporin antibiotics. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Special care is indicated in patients who have experienced an allergic reaction to penicillins or other beta-lactams.</p><p>&nbsp;</p><p>Cephalosporin antibiotics at high dosage should be given with caution to patients receiving concurrent treatment with potent diuretics such as furosemide or aminoglycosides, as renal impairment has been reported with these combinations. Renal function should be monitored in these patients, the elderly, and those with pre-existing renal impairment (<em>see Dosage and Administration).</em></p><p>&nbsp;</p><p>As with other therapeutic regimens used in the treatment of meningitis, mild-to-moderate hearing loss has been reported in a few paediatric patients treated with <em>ZINACEF</em>. Persistence of positive cerebral spinal fluid (CSF) cultures of <em>Haemophilus influenzae </em>at 18-36 hours has also been noted with <em>ZINACEF </em>injection, as well as with other antibiotic therapies; however, the clinical relevance of this is unknown.</p><p>As with other antibiotics, use of <em>ZINACEF </em>may result in the overgrowth of <em>Candida</em>.</p><p>Prolonged use may also result in the overgrowth of other non-susceptible organisms (e.g. enterococci and <em>Clostridioides</em><em> difficile</em>), which may require interruption of treatment.</p><p>&nbsp;</p><p>Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use. If prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.</p><p>&nbsp;</p><p><strong>Intracameral use and ocular toxicity</strong></p><p>Serious ocular toxicity, including corneal opacity, retinal toxicity and visual impairment has been reported following off-label intracameral use of ZINACEF. ZINACEF should not be administered intracamerally.</p><p>&nbsp;</p><p>With a sequential therapy regime the timing of change to oral therapy is determined by severity of the infection, clinical status of the patient and susceptibility of the pathogens involved. If there is no clinical improvement within 72 hours, then the parenteral course of treatment must be continued.</p><p>&nbsp;</p><p>Refer to the relevant prescribing information for <em>ZINNAT </em>before initiating sequential therapy.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In common with other antibiotics, <em>ZINACEF </em>may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p>&nbsp;</p><p><em>ZINACEF </em>does not interfere in enzyme-based tests for glycosuria.</p><p>&nbsp;</p><p>Slight interference with copper reduction methods (Benedict&#39;s, Fehling&#39;s, Clinitest) may be observed. However, this should not lead to false-positive results, as may be experienced with some other cephalosporins.</p><p>&nbsp;</p><p>It is recommended that either the glucose oxidase or hexokinase methods are used to determine blood/plasma glucose levels in patients receiving <em>ZINACEF</em>.</p><p>&nbsp;</p><p>This antibiotic does not interfere in the alkaline picrate assay for creatinine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no experimental evidence of embryopathic or teratogenic effects attributable to <strong><em>cefuroxime</em></strong>, but, as with all drugs, it should be administered with caution during the early months of pregnancy. Cefuroxime is excreted in human milk, and consequently caution should be exercised when <em>ZINACEF </em>is administered to a nursing mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions are very rare (&lt;1/10,000) and are generally mild and transient in nature.</p><p>&nbsp;</p><p>The frequency categories assigned to the adverse reactions below are estimates, as for most reactions suitable data for calculating incidence are not available. In addition the incidence of adverse reactions associated with <em>ZINACEF </em>may vary according to the indication.</p><p>&nbsp;</p><p>Data from clinical trials were used to determine the frequency of very common to rare undesirable effects. The frequencies assigned to all other undesirable effects (i.e., those occurring at &lt;1/10<strong>,</strong>00<strong>0</strong>) were mainly determined using post-marketing data and refer to a reporting rate rather than a true frequency.</p><p>The following convention has been used for the classification of frequency:</p><p>Very common &ge;1/10,</p><p>Common &ge;1/100 to &lt;1/10,</p><p>Uncommon &ge;1/1000 to &lt;1/100,</p><p>Rare &ge;1/10,000 to &lt;1/1000, Very rare &lt;1/10,000.</p><p>&nbsp;</p><p><strong>Infections and infestations</strong></p><p>&nbsp;</p><p>Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Candida overgrowth</p><p>&nbsp;</p><p>Blood and lymphatic system disorders</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:492px"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Neutropenia, eosinophilia.</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Leukopenia, decreased haemoglobin concentration<strong><em>,</em></strong> positive Coomb&rsquo;s test.</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Thrombocytopenia.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Haemolytic anaemia.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>Cephalosporins as a class tend to be absorbed onto the surface of red cell membranes and react with antibodies directed against the drug to produce a positive Coomb&rsquo;s Test (which can interfere with cross matching of blood) and very rarely haemolytic anaemia.</p><p>&nbsp;</p><p>&nbsp;</p><p>Immune system disorders</p><p>&nbsp;</p><p>Hypersensitivity reactions including</p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash, urticaria and pruritus<strong>. </strong></p><p>Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drug fever.</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interstitial nephritis, anaphylaxis, cutaneous vasculitis.</p><p>See also Skin and subcutaneous tissue disorders and Renal and urinary disorders. <strong>Gastrointestinal disorders</strong></p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastrointestinal disturbance.</p><p>&nbsp;</p><p>Very rare Pseudomembranous colitis (<strong><em>s</em></strong><em>ee Warnings and Precautions</em>).</p><p>&nbsp;</p><p>&nbsp;</p><p>Hepatobiliary disorders</p><p>&nbsp;</p><p>Common &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transient rise in liver enzymes.</p><p>&nbsp;</p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transient rise in bilirubin.</p><p>&nbsp;</p><p>&nbsp;</p><p>Transient rises in serum liver enzymes or bilirubin occur, particularly in patients with pre-existing liver disease, but there is no evidence of harm to the liver.</p><p>&nbsp;</p><p>Skin and subcutaneous tissue disorders</p><p>&nbsp;</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythema multiforme, toxic epidermal necrolysis and Stevens</p><p>Johnson Syndrome.</p><p>&nbsp;</p><p>See also Immune system disorders.</p><p>&nbsp;</p><p>Renal and urinary disorders</p><p>&nbsp;</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elevations in serum creatinine, elevations in blood urea nitrogen and decreased creatinine clearance (<strong><em>s</em></strong><em>ee Warnings and Precautions).</em></p><p>&nbsp;</p><p>See also Immune system disorders.</p><p>&nbsp;</p><p>General disorders and administration site conditions</p><p>&nbsp;</p><p>Common &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Injection site reactions which may include pain and thrombophlebitis.</p><p>&nbsp;</p><p>Pain at the intramuscular injection site is more likely at higher doses. However, it is unlikely to be a cause for discontinuation of treatment.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><p>Kingdom of Saudi Arabia</p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting Hotline: 19999E-mail: npc.drug@sfda.gov.sa</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel: 00966(012)6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: <u>s</u>audi.safety@gsk.com<u>&nbsp; </u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O Box 55850, Jeddah 21544, Saudi Arabia.</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GlaxoSmithKline - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage of cephalosporins can cause cerebral irritation leading to convulsions. Serum levels of cefuroxime can be reduced by haemodialysis or peritoneal dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefuroxime is a well characterised and effective antibacterial agent which has bactericidal activity against a wide range of common pathogens, including <sub>&beta;</sub>-lactamase producing strains. Cefuroxime has good stability to bacterial <sub>&beta;</sub>-lactamase, and consequently is active against many ampicillin-resistant or amoxycillin-resistant strains.</p><p>&nbsp;</p><p>The bactericidal action of cefuroxime results from inhibition of cell wall synthesis by binding to essential target proteins.</p><p>&nbsp;</p><p>The prevalence of acquired resistance is geographically and time dependent and for select species may be very high. Local information on resistance is desirable, particularly when treating severe infections.</p><p>&nbsp;</p><table cellspacing="1" cellpadding="1" border="1" style="width:500px"><tbody><tr><td><p><strong><em>In vitro </em></strong><strong>susceptibility of micro-organisms to Cefuroxime</strong></p><p>Where clinical efficacy of cefuroxime has been demonstrated in clinical trials this is indicated with an asterisk (*).</p></td></tr><tr><td><strong>Commonly Susceptible Species</strong></td></tr><tr><td><p><u>Gram-Positive Aerobes:</u></p><em>Staphylococcus aureus </em>(methicillin susceptible)*</td></tr></tbody></table><p>&nbsp;</p><table cellspacing="1" cellpadding="1" border="1" style="width:500px"><tbody><tr><td><em>Coagulase negative staphylococcus </em>(methicillin susceptible) <em>Streptococcus pyogenes</em>* Betahemolytic streptococci</td></tr><tr><td><p><u>Gram-Negative Aerobes:</u></p><p><em>Haemophilus influenzae </em>including ampicillin resistant strains*</p><p><em>Haemophilus parainfluenzae</em>*</p><p><em>Moraxella catarrhalis</em>*</p><p><em>Neisseria gonorrhoea</em>* including penicillinase and non-penicillinase producing strains</p><p><em>Neisseria meningitidis Shigella </em>spp.</p></td></tr><tr><td><p><u>Gram-Positive Anaerobes:</u></p><p><em>Peptostreptococcus </em>spp.</p><p><em>Propionibacterium </em>spp.</p></td></tr><tr><td><p><u>Spirochetes:</u></p><p><em>Borrelia burgdorferi</em>*</p></td></tr><tr><td><strong>Organisms for which acquired resistance may be a problem</strong></td></tr><tr><td><p><u>Gram-Positive Aerobes:</u></p><p><em>Streptococcus pneumoniae</em>*</p><p>Viridans group streptococcus</p><p><u>Gram-Negative Aerobes:</u></p><p><em>Bordetella pertussis</em></p><p><em>Citrobacter </em>spp. not including <em>C. freundii</em></p><p><em>Enterobacter </em>spp. not including <em>E. aerogenes </em>and <em>E. cloacae </em></p><p><em>Escherichia coli</em>*</p><p><em>Klebsiella </em>spp. including <em>K. pneumoniae</em>*</p><p><em>Proteus mirabilis</em></p><p><em>Proteus </em>spp. not including <em>P. penneri </em>and <em>P. vulgaris Providencia </em>spp.</p><p><em>Salmonella </em>spp.</p></td></tr><tr><td><u>Gram-Positive Anaerobes:</u></td></tr></tbody></table><table cellspacing="1" cellpadding="1" border="1" style="width:500px"><tbody><tr><td><table cellspacing="0" cellpadding="0" border="0" style="width:433.3pt"><tbody><tr><td style="border-color:black; height:21.95pt; vertical-align:top; width:420.85pt"><p>Clostridium spp.</p></td></tr></tbody></table></td></tr><tr><td><p><u>Gram-Negative Anaerobes:</u></p><p><em>Bacteroides </em>spp. not including <em>B. fragilis Fusobacterium </em>spp.</p></td></tr><tr><td><strong>Inherently resistant organisms</strong></td></tr><tr><td><p><u>Gram-Positive Aerobes:</u></p><p><em>Enterococcus </em>spp. including <em>E. faecalis </em>and <em>E. faecium </em></p><p><em>Listeria&nbsp; monocytogenes</em></p></td></tr><tr><td><p><u>Gram-Negative Aerobes:</u></p><p><em>Acinetobacter </em>spp. <em>Burkholderia cepacia Campylobacter </em>spp.</p><p><em>Citrobacter freundii </em></p><p><em>Enterobacter aerogenes </em></p><p><em>Enterobacter cloacae </em></p><p><em>Morganella morganii </em></p><p><em>Proteus penneri </em></p><p><em>Proteus vulgaris</em></p><p><em>Pseudomonas </em>spp. including <em>P. aeruginosa Serratia </em>spp.</p><p><em>Stenotrophomonas maltophilia</em></p></td></tr><tr><td><p><u>Gram-Positive Anaerobes:</u></p>Clostridioides difficile</td></tr><tr><td><p><u>Gram-Negative Anaerobes:</u></p><em><em>Bacteroides fragilis</em> </em></td></tr><tr><td><p><u>Others:</u></p><p><em>Chlamydia </em>species</p><p><em>Mycoplasma </em>species</p><p><em>Legionella </em>species</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Peak levels of cefuroxime are achieved within 30 to 45 minutes after i.m. administration.</p><p>&nbsp;</p><p>Protein binding has been variously stated as 33 - 50% depending on the methodology used.</p><p>&nbsp;</p><p>Concentrations of cefuroxime in excess of the minimum inhibitory levels for common pathogens can be achieved in bone, synovial fluid and aqueous humour. Cefuroxime passes the blood-brain barrier when the meninges are inflamed.</p><p>&nbsp;</p><p>Cefuroxime is not metabolised and is excreted by glomerular filtration and tubular secretion.</p><p>&nbsp;</p><p>The serum half-life after either i.m. or i.v. injection is approximately 70 minutes.</p><p>&nbsp;</p><p>In the first weeks of life the serum half-life of cefuroxime can be 3 to 5 times that in the adult.</p><p>&nbsp;</p><p>Concurrent administration of probenecid prolongs the excretion of the antibiotic and produces an elevated peak serum level.</p><p>&nbsp;</p><p>There is an almost complete recovery (85 to 90%) of unchanged cefuroxime in urine within 24 hours of administration. The major part is excreted in the first 6 hours.</p><p>&nbsp;</p><p>Serum levels of cefuroxime are reduced by dialysis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No additional data of relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p><p>Each 750 mg vial contains 42 mg sodium (1.8 mEq).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>ZINACEF should not be mixed in the syringe with aminoglycoside antibiotics.</strong></p><p><strong>&nbsp;</strong></p><p>The pH of 2.74% w/v Sodium Bicarbonate Injection BP considerably affects the colour of the solution and therefore this solution is not recommended for the dilution of ZINACEF. However, if required, for patients receiving Sodium Bicarbonate Injection by infusion ZINACEF may be introduced into the tube of the giving set.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date of the powder is indicated on the packaging. 

The unopened pack storage temperature requirements are indicated on the packaging.
If unopened product previously stored below 25oC
Shelf life after reconstitution and dilution under controlled and validated aseptic conditions:
suspension and solution for Injection -5 hours below 25oC or 72 hours at 2 to 8oC

Shelf life if reconstitution and dilution has not taken place in controlled and validated aseptic conditions:

The product should be used immediately or within 24 hours if stored at 2 to 8oC.

If unopened product previously stored below 30oC
Shelf life after reconstitution and dilution under controlled and validated aseptic conditions:
Suspension and solution for Injection - 5 hours below 25oC or 72 hours at 2 to 8oC
Solution for Infusion - Use immediately or within 24 hours at 2° to 8°C 
Shelf life if reconstitution and dilution has not taken place in controlled and validated aseptic conditions:
The product should be used immediately or within 24 hours if stored at 2° to 8°C. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The storage conditions are detailed on the packaging.</p><p>Store in original package to protect from light.</p><p>&nbsp;</p><p>Some increase in the colour of prepared solutions and suspensions of <em>ZINACEF </em>may occur on storage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As registered locally.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use and Handling</p><p>&nbsp;</p><p>Intramuscular</p><p>&nbsp;</p><p>Add 3 ml Water for Injections to</p><p>750 mg <em>ZINACEF</em>. Shake gently to produce an opaque suspension.</p><p>&nbsp;</p><p>Intravenous</p><p>&nbsp;</p><p>Dissolve <em>ZINACEF </em>in Water for Injections using, at least 6 ml for 750 mg, or 15 ml for 1.5 g.</p><p>&nbsp;</p><p>Intravenous infusion</p><p>&nbsp;</p><p>Dissolve 1.5 g of <em>ZINACEF </em>in 15 ml of Water for Injections.&nbsp; Add the reconstituted solution of <em>ZINACEF </em>to 50 or 100 ml of a compatible infusion fluid (see information on Compatibility below) These solutions may be given directly into the vein or introduced into the tubing of the giving set if the patient is receiving parenteral fluids.</p><p>&nbsp;</p><p>Compatibility</p><p>1.5 g <em>ZINACEF </em>constituted with 15 ml Water for Injections may be added to metronidazole injection (500 mg/100 ml)</p><p>&nbsp;</p><p>1.5 g <em>ZINACEF </em>is compatible with azlocillin 1 g (in 15 ml) or 5 g (in 50 ml) .</p><p>&nbsp;</p><p><em>ZINACEF </em>(5 mg/ml) is compatible with 5% w/v or 10% w/v xylitol injection .</p><p>&nbsp;</p><p>ZINACEF may be constituted for i.m use with aqueous solutions containing up to 1% lidoocaine hydrochloride.</p><p>&nbsp;</p><p>ZINACEF is compatible with the following more commonly used i.v. infusion fluids<strong>: </strong></p><p>&nbsp;</p><p>Sodium Chloride Injection BP 0.9% w/v 5% Dextrose Injection BP.</p><p>0.18% w/v Sodium Chloride plus 4% Dextrose Injection BP</p><p>5% Dextrose and 0.9% Sodium Chloride Injection</p><p>5% Dextrose and 0.45% Sodium Chloride Injection</p><p>5% Dextrose and 0.225% Sodium Chloride Injection</p><p>10% Dextrose Injection</p><p>10% Invert Sugar in Water for Injection Ringer&#39;s Injection USP</p><p>Lactated Ringer&#39;s Injection USP</p><p>M/6 Sodium Lactate Injection</p><p>Compound Sodium Lactate Injection BP (Hartmann&#39;s Solution).</p><p>&nbsp;</p><p>The stability of <em>ZINACEF </em>in Sodium Chloride Injection BP 0.9% w/v and in 5%</p><p>Dextrose Injection is not affected by the presence of hydrocortisone sodium phosphate.</p><p>&nbsp;</p><p><em>ZINACEF </em>has also been found compatible admixed in i.v. infusion with: Heparin (10 and 50 units/ml) in 0.9% Sodium Chloride Injection; Potassium Chloride (10 and 40 mEqL) in 0.9% Sodium Chloride Injection.</p><p>&nbsp;</p><p>&nbsp;</p><p>Not all presentations are available in every country.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by: 
GlaxoSmithKline Manufacturing Sp.A* Verona, Italy.
Packed by: 
Glaxo Saudi Arabia Ltd.* Jeddah, KSA 
Marketing Authorization Holder: 
Glaxo Saudi Arabia Ltd.* Jeddah, KSA 
*member of the GlaxoSmithKline group of companies 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: GDS33/IPI09 
Date of issue: 26 March 2020
 

Trademarks are owned by or licensed to the GSK group of companies.
© 2020 GlaxoSmithKline group of companies, all rights reserved. 

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>